[go: up one dir, main page]

Kwon et al., 2018 - Google Patents

Large‐scale synthesis and medical applications of uniform‐sized metal oxide nanoparticles

Kwon et al., 2018

View PDF
Document ID
2902836430827665671
Author
Kwon H
Shin K
Soh M
Chang H
Kim J
Lee J
Ko G
Kim B
Kim D
Hyeon T
Publication year
Publication venue
Advanced Materials

External Links

Snippet

Thanks to recent advances in the synthesis of high‐quality inorganic nanoparticles, more and more types of nanoparticles are becoming available for medical applications. Especially, metal oxide nanoparticles have drawn much attention due to their unique …
Continue reading at pr.ibs.re.kr (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb

Similar Documents

Publication Publication Date Title
Kwon et al. Large‐scale synthesis and medical applications of uniform‐sized metal oxide nanoparticles
Ganapathe et al. Magnetite (Fe3O4) nanoparticles in biomedical application: From synthesis to surface functionalisation
Wu et al. Designed synthesis and surface engineering strategies of magnetic iron oxide nanoparticles for biomedical applications
Liang et al. Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies
Das et al. Tailor made magnetic nanolights: Fabrication to cancer theranostics applications
Baabu et al. Iron oxide nanoparticles: a review on the province of its compounds, properties and biological applications
Soufi et al. Eco-friendly and sustainable synthesis of biocompatible nanomaterials for diagnostic imaging: current challenges and future perspectives
Unni et al. Thermal decomposition synthesis of iron oxide nanoparticles with diminished magnetic dead layer by controlled addition of oxygen
Fernández-Barahona et al. Microwave-driven synthesis of iron-oxide nanoparticles for molecular imaging
Nikazar et al. Photo‐and magnetothermally responsive nanomaterials for therapy, controlled drug delivery and imaging applications
Shen et al. Iron oxide nanoparticle based contrast agents for magnetic resonance imaging
Antwi‐Baah et al. Metal‐based nanoparticle magnetic resonance imaging contrast agents: classifications, issues, and countermeasures toward their clinical translation
Wei et al. Facile synthesis of uniform-sized bismuth nanoparticles for CT visualization of gastrointestinal tract in vivo
Patsula et al. Superparamagnetic Fe3O4 nanoparticles: synthesis by thermal decomposition of iron (III) glucuronate and application in magnetic resonance imaging
Yang et al. Multifunctional self-assembled supernanoparticles for deep-tissue bimodal imaging and amplified dual-mode heating treatment
Zhang et al. Manganese doped iron oxide theranostic nanoparticles for combined T 1 magnetic resonance imaging and photothermal therapy
Kim et al. Scalable solvothermal synthesis of superparamagnetic Fe3O4 nanoclusters for bioseparation and theragnostic probes
Silva et al. Gold coated magnetic nanoparticles: from preparation to surface modification for analytical and biomedical applications
Cai et al. Large-scale, facile transfer of oleic acid-stabilized iron oxide nanoparticles to the aqueous phase for biological applications
Peng et al. Nanostructured magnetic nanocomposites as MRI contrast agents
Strable et al. Synthesis and characterization of soluble iron oxide− dendrimer composites
Lee et al. Multifunctional Fe3O4/TaO x Core/Shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography
Ding et al. Fe3O4@ SiO2 core/shell nanoparticles: the silica coating regulations with a single core for different core sizes and shell thicknesses
Zhen et al. Comparative study of the magnetic behavior of spherical and cubic superparamagnetic iron oxide nanoparticles
Yusoff et al. A review: Synthetic strategy control of magnetite nanoparticles production